320 related articles for article (PubMed ID: 32366279)
1. Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
Chai P; Yu J; Ge S; Jia R; Fan X
J Hematol Oncol; 2020 May; 13(1):43. PubMed ID: 32366279
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
3. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
Chen L; Li X; Chen M; Feng Y; Xiong C
Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
[TBL] [Abstract][Full Text] [Related]
4. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
Qi F; Qian S; Zhang S; Zhang Z
Biochem Biophys Res Commun; 2020 May; 526(1):135-140. PubMed ID: 32199615
[TBL] [Abstract][Full Text] [Related]
5. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract][Full Text] [Related]
6. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19.
Li G; He X; Zhang L; Ran Q; Wang J; Xiong A; Wu D; Chen F; Sun J; Chang C
J Autoimmun; 2020 Aug; 112():102463. PubMed ID: 32303424
[TBL] [Abstract][Full Text] [Related]
7. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection.
Kong Q; Xiang Z; Wu Y; Gu Y; Guo J; Geng F
Mol Cancer; 2020 Apr; 19(1):80. PubMed ID: 32345328
[TBL] [Abstract][Full Text] [Related]
9. Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?
Gracia-Ramos AE
Arch Med Res; 2020 May; 51(4):345-346. PubMed ID: 32279908
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.
Barker H; Parkkila S
PLoS One; 2020; 15(10):e0240647. PubMed ID: 33112891
[TBL] [Abstract][Full Text] [Related]
12. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F
Clin Chem Lab Med; 2020 Aug; 58(9):1415-1422. PubMed ID: 32598305
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
Öztürk AB; Çağlayan B
Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
[No Abstract] [Full Text] [Related]
14. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
15. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
Damas J; Hughes GM; Keough KC; Painter CA; Persky NS; Corbo M; Hiller M; Koepfli KP; Pfenning AR; Zhao H; Genereux DP; Swofford R; Pollard KS; Ryder OA; Nweeia MT; Lindblad-Toh K; Teeling EC; Karlsson EK; Lewin HA
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22311-22322. PubMed ID: 32826334
[TBL] [Abstract][Full Text] [Related]
16. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
18. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
Huang X; He C; Hua X; Kan A; Sun S; Wang J; Li S
Int J Biol Sci; 2020; 16(13):2464-2476. PubMed ID: 32760213
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
